Lutetium-177

Radioligand Therapy

New Cancer Treatment – Why Experts Say Radioligand Therapy Is a Game-Changer

What Is Radioligand Therapy? Mechanism of Action Radioligand therapy is a targeted radiotherapy approach. A therapeutic agent is made of a radioactive isotope (emitting beta or alpha particles) linked to a ligand that binds a molecule on cancer cells siemens-healthineers.com, healthsystemreadiness.com. For example, lutetium-177 dotatate attaches to somatostatin receptors on neuroendocrine tumors,
September 15, 2025